期刊文献+

格列吡嗪控释片对2型糖尿病空腹血糖和晚餐后2h血糖的疗效观察 被引量:5

Effect of Glipizide GITS on the fasting plasma glucose and plasma glucose of 2 hours after supper in patients with type 2 diabetes
下载PDF
导出
摘要 目的 :观察格列吡嗪控释片 (瑞易宁 )对 2型糖尿病患者空腹和晚餐后 2h血糖的影响。方法 :3 0例住院的 2型糖尿病患者经严格的饮食控制 3~ 5d后 ,血糖仍未达标者口服瑞易宁 5mg/d ,5d后血糖仍未控制者增加至 10mg/d ,最大服药剂量 2 0mg/d。服药前后均检测空腹和晚餐后血糖。 结果 :治疗前平均空腹血糖 8 97± 1 17mmol/L ,晚餐后 2h血糖11 2 4± 3 18mmol/L ;治疗 2周后空腹血糖 5 3 1± 1 0 4mmol/L ,晚餐后 2h血糖 7 0 8± 1 14mmol/L。所有病例均未发生特殊不良反应。结论 :瑞易宁治疗 2型糖尿病能有效控制空腹和餐后血糖 ,是治疗 2型糖尿病的有效药物 ,耐受性好 ,服用方便。 Objective To investigate the effect of Glipizide (Glipizide GITS)on the fasting plasma glucose and plasma glucose of 2 hours after supper in patients with type 2 diabetes.Methods Thirty patients were controlled diet strictly for 3~5 days,but the plasma glucose could not reach the criteria.All patients started treatment with 5 mg of Glipizide GITS and were added,if necessary,to 10?15 or 20mg.The fasting plasma glucose and plasma glucose of 2 hours after supper were evaluated before and after treatment.Results Before treatment the fasting plasma glucose was 8.97±1.17mmol/L.The plasma glucose of 2 hours after supper was 11.24±3.18mmol/L.After treatment the fasting plasma glucose was 5.31±1.04mmol/L,The plasma glucose of 2 hours after supper was 7.08±1.14mmol/L.No side effect occurred.Conclusion Glipizide GITS is effective and safe in the treatment of type 2 diabetes.
出处 《实用诊断与治疗杂志》 2003年第3期176-177,共2页 Journal of Practical Diagnosis and Therapy
关键词 格列吡嗪控释片 2型糖尿病 空腹 血糖 晚餐后 2H血糖 疗效观察 Glipizide(Glipizide GITS) type 2 diabetes the fasting plasma glucose the plasma glucose of 2 hours after supper
  • 相关文献

参考文献6

  • 1陆菊明.糖尿病患者口服降糖药的治疗[J].中华内科杂志,2002,41(6):428-429. 被引量:27
  • 2Swanson DR, Barclay BL, Wong PSL, et al. Nifedipine gastronintestina therapeutic system. Am J Med, 1987,83(Suppl 6B):3.
  • 3Chung M, Reitberg DP,Gaffney M,et al. Clinical pharmacokintics of nifedipine gastronintestinal therapeutic system:a controlled-release fornulation of nifedipine. Am J Med, 1987,83(Suppl 6 B) : 10.
  • 4Berelowitz M,Fischette C,Cefalu W,et al. Comparative efficacy of a oncedaily controlled-release formulation of glipizide and immediate- releaseglipizide in patients with NIDDM. Diabetes Care, 1994,17:1460.
  • 5Berelowitz M. Contrasting influences of glipizide GITS and glibenlamide on fasting and post sustacal glycemia,glucose production,and 24h glucose/insulin profiles in NIDDM. Diabetes, 1996,45 (Suppl2) :285A.
  • 6Cefalu WT,BelI-Farrow AD, Wang ZQ, et al. Insulin sensitivity in vivo is improved after glipizide GITS treament. Diabetes, 1995,44(Suppl 2) : 107A.

共引文献26

同被引文献48

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部